Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR...

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: HemaSphere
Personen und Körperschaften: Goekbuget, N., Dombret, H., Zugmaier, G., Bonifacio, M., Graux, C., Faul, C., Topp, M.S., Brüggemann, M., Taylor, K., Bargou, R.
In: HemaSphere, 3, 2019, S1, S. 747-748
Format: E-Article
Sprache: Englisch
veröffentlicht:
Wiley
Schlagwörter:
Hematology
author_facet Goekbuget, N.
Dombret, H.
Zugmaier, G.
Bonifacio, M.
Graux, C.
Faul, C.
Topp, M.S.
Brüggemann, M.
Taylor, K.
Bargou, R.
Goekbuget, N.
Dombret, H.
Zugmaier, G.
Bonifacio, M.
Graux, C.
Faul, C.
Topp, M.S.
Brüggemann, M.
Taylor, K.
Bargou, R.
author Goekbuget, N.
Dombret, H.
Zugmaier, G.
Bonifacio, M.
Graux, C.
Faul, C.
Topp, M.S.
Brüggemann, M.
Taylor, K.
Bargou, R.
spellingShingle Goekbuget, N.
Dombret, H.
Zugmaier, G.
Bonifacio, M.
Graux, C.
Faul, C.
Topp, M.S.
Brüggemann, M.
Taylor, K.
Bargou, R.
HemaSphere
S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
Hematology
author_sort goekbuget, n.
spelling Goekbuget, N. Dombret, H. Zugmaier, G. Bonifacio, M. Graux, C. Faul, C. Topp, M.S. Brüggemann, M. Taylor, K. Bargou, R. 2572-9241 Wiley Hematology http://dx.doi.org/10.1097/01.hs9.0000564724.75061.cc S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS HemaSphere
doi_str_mv 10.1097/01.hs9.0000564724.75061.cc
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMS5oczkuMDAwMDU2NDcyNC43NTA2MS5jYw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMS5oczkuMDAwMDU2NDcyNC43NTA2MS5jYw
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Wiley, 2019
imprint_str_mv Wiley, 2019
issn 2572-9241
issn_str_mv 2572-9241
language English
mega_collection Wiley (CrossRef)
match_str goekbuget2019s1619blinatumomabforminimalresidualdiseasemrdinadultswithbcellprecursoracutelymphoblasticleukemiabcpallmedianoverallsurvivalosnotreachedat5yearsforcompletemrdresponders
publishDateSort 2019
publisher Wiley
recordtype ai
record_format ai
series HemaSphere
source_id 49
title S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_unstemmed S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_full S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_fullStr S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_full_unstemmed S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_short S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_sort s1619 blinatumomab for minimal residual disease (mrd) in adults with bcell precursor acute lymphoblastic leukemia (bcpall): median overall survival (os) not reached at 5 years for complete mrd responders
topic Hematology
url http://dx.doi.org/10.1097/01.hs9.0000564724.75061.cc
publishDate 2019
physical 747-748
description
container_issue S1
container_start_page 747
container_title HemaSphere
container_volume 3
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340614282477573
geogr_code not assigned
last_indexed 2024-03-01T16:06:46.078Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=S1619+BLINATUMOMAB+FOR+MINIMAL+RESIDUAL+DISEASE+%28MRD%29+IN+ADULTS+WITH+BCELL+PRECURSOR+ACUTE+LYMPHOBLASTIC+LEUKEMIA+%28BCPALL%29%3A+MEDIAN+OVERALL+SURVIVAL+%28OS%29+NOT+REACHED+AT+5+YEARS+FOR+COMPLETE+MRD+RESPONDERS&rft.date=2019-06-01&genre=article&issn=2572-9241&volume=3&issue=S1&spage=747&epage=748&pages=747-748&jtitle=HemaSphere&atitle=S1619+BLINATUMOMAB+FOR+MINIMAL+RESIDUAL+DISEASE+%28MRD%29+IN+ADULTS+WITH+BCELL+PRECURSOR+ACUTE+LYMPHOBLASTIC+LEUKEMIA+%28BCPALL%29%3A+MEDIAN+OVERALL+SURVIVAL+%28OS%29+NOT+REACHED+AT+5+YEARS+FOR+COMPLETE+MRD+RESPONDERS&aulast=Bargou&aufirst=R.&rft_id=info%3Adoi%2F10.1097%2F01.hs9.0000564724.75061.cc&rft.language%5B0%5D=eng
SOLR
_version_ 1792340614282477573
author Goekbuget, N., Dombret, H., Zugmaier, G., Bonifacio, M., Graux, C., Faul, C., Topp, M.S., Brüggemann, M., Taylor, K., Bargou, R.
author_facet Goekbuget, N., Dombret, H., Zugmaier, G., Bonifacio, M., Graux, C., Faul, C., Topp, M.S., Brüggemann, M., Taylor, K., Bargou, R., Goekbuget, N., Dombret, H., Zugmaier, G., Bonifacio, M., Graux, C., Faul, C., Topp, M.S., Brüggemann, M., Taylor, K., Bargou, R.
author_sort goekbuget, n.
container_issue S1
container_start_page 747
container_title HemaSphere
container_volume 3
description
doi_str_mv 10.1097/01.hs9.0000564724.75061.cc
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMS5oczkuMDAwMDU2NDcyNC43NTA2MS5jYw
imprint Wiley, 2019
imprint_str_mv Wiley, 2019
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 2572-9241
issn_str_mv 2572-9241
language English
last_indexed 2024-03-01T16:06:46.078Z
match_str goekbuget2019s1619blinatumomabforminimalresidualdiseasemrdinadultswithbcellprecursoracutelymphoblasticleukemiabcpallmedianoverallsurvivalosnotreachedat5yearsforcompletemrdresponders
mega_collection Wiley (CrossRef)
physical 747-748
publishDate 2019
publishDateSort 2019
publisher Wiley
record_format ai
recordtype ai
series HemaSphere
source_id 49
spelling Goekbuget, N. Dombret, H. Zugmaier, G. Bonifacio, M. Graux, C. Faul, C. Topp, M.S. Brüggemann, M. Taylor, K. Bargou, R. 2572-9241 Wiley Hematology http://dx.doi.org/10.1097/01.hs9.0000564724.75061.cc S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS HemaSphere
spellingShingle Goekbuget, N., Dombret, H., Zugmaier, G., Bonifacio, M., Graux, C., Faul, C., Topp, M.S., Brüggemann, M., Taylor, K., Bargou, R., HemaSphere, S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS, Hematology
title S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_full S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_fullStr S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_full_unstemmed S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_short S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
title_sort s1619 blinatumomab for minimal residual disease (mrd) in adults with bcell precursor acute lymphoblastic leukemia (bcpall): median overall survival (os) not reached at 5 years for complete mrd responders
title_unstemmed S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
topic Hematology
url http://dx.doi.org/10.1097/01.hs9.0000564724.75061.cc